Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3 Trial of Dichloroacetate in Pyruvate Dehydrogenase Complex Deficiency:

NCT02616484 is registered in ClinicalTrials.gov with Saol Therapeutics Inc as lead sponsor.

NCT NCT02616484
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02616484 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3 Trial of Dichloroacetate in Pyruvate Dehydrogenase Complex Deficiency:
Lead sponsor
Saol Therapeutics Inc
Phase
Phase 3
Overall status
Active, not recruiting
Start date
July 14, 2020
Completion date
August 27, 2025
Enrollment
34 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

pyruvate dehydrogenase complex deficiency